Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Revenue: 2012-2024

Historic Revenue for Ascendis Pharma A (ASND) over the last 13 years, with Dec 2024 value amounting to $393.6 million.

  • Ascendis Pharma A's Revenue rose 293.22% to $249.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $720.7 million, marking a year-over-year increase of 103.23%. This contributed to the annual value of $393.6 million for FY2024, which is 37.15% up from last year.
  • Per Ascendis Pharma A's latest filing, its Revenue stood at $393.6 million for FY2024, which was up 37.15% from $287.0 million recorded in FY2023.
  • Ascendis Pharma A's 5-year Revenue high stood at $393.6 million for FY2024, and its period low was $7.9 million during FY2020.
  • Moreover, its 3-year median value for Revenue was $287.0 million (2023), whereas its average is $244.3 million.
  • Data for Ascendis Pharma A's Revenue shows a peak YoY soared of 19,527.55% (in 2020) over the last 5 years.
  • Over the past 5 years, Ascendis Pharma A's Revenue (Yearly) stood at $7.9 million in 2020, then rose by 12.08% to $8.9 million in 2021, then skyrocketed by 486.78% to $52.2 million in 2022, then spiked by 449.65% to $287.0 million in 2023, then surged by 37.15% to $393.6 million in 2024.